Dr. Edward Obedian, MD

Dr. Obedian practices at St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre.

Dr. Obedian's NPI, 1508808213, was assigned on June 10, 2006. Dr. Obedian graduated from Boston University School Of Medicine in 1995. Dr. Obedian's New York license number on file is 218952.

Dr. Obedian's primary practice is St. Francis Hospital & Heart Center, at 100 Port Washington Boulevard, Roslyn, NY 11576 in Nassau County. The practice phone is (516) 562-6000.

Dr. Obedian's primary practice is St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre. Dr. Obedian is also affiliated with Mercy Hospital. The medical group on file is Cardiac Interventional Group. Dmand AI also links Dr. Obedian to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Obedian practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Obedian's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Obedian is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Obedian's licenses on file in 3 states: New York, California and Connecticut.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Obedian treats.

CMS data shows 1,755 Medicare services from Dr. Obedian across 20 procedure codes in 2024, for 154 Medicare patients. Medicare paid $179,653 for them. Every service was in an office.

CMS counts 154 Medicare patients who saw Dr. Obedian in 2024. The largest group is 75 to 84, with 72 patients. 75% of them have cancer, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Obedian's median patient age at 77, with 39% women.

In 2024, Dr. Obedian wrote 39 Medicare Part D claims for 30 patients. 56% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $198 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Obedian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Obedian. Dr. Obedian's most frequent co-authors are Allen M. Chen, MD and Bruce G. Haffty, MD.

CMS Open Payments shows 465 general payments to Dr. Obedian from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Progenics Pharmaceuticals, Inc. paid the most, $366,069.

Dr. Obedian graduated from Boston University School Of Medicine in 1995.

Dr. Obedian is in network with 16 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.